Tag Archives: dual inhibitor
Discovery of potential anti-breast cancer agents dual targeting ER and VEGFR-2
Breast cancer (BC) is the most common cancer in females worldwide. Among all BC patients, more than 70% are diagnosed as estrogen receptor positive (ER+). Estrogen is the primary female hormone which is responsible for the development
